嘉实中证疫苗与生物技术ETF(562860)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
43,527.90 |
109,305.80 |
12,123.21 |
125,407.47 |
存出保证金 |
13,266.37 |
16,867.02 |
12,957.55 |
47,992.36 |
交易性金融资产 |
247,275,707.91 |
288,953,460.11 |
295,334,044.64 |
490,482,438.09 |
其中:股票投资 |
247,275,707.91 |
288,953,460.11 |
295,334,044.64 |
490,482,438.09 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
- |
683,574.26 |
7,334.54 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
- |
- |
- |
26,532.99 |
资产总计 |
250,610,591.14 |
292,833,452.44 |
300,312,099.27 |
495,946,132.65 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
671,958.23 |
80,947.69 |
544,290.89 |
- |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
104,189.15 |
132,038.29 |
129,693.19 |
211,779.42 |
应付托管费 |
20,837.82 |
26,407.65 |
25,938.66 |
42,355.87 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
2,711.81 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
90,852.99 |
158,423.41 |
122,973.29 |
283,487.23 |
负债合计 |
887,838.19 |
397,817.04 |
822,896.03 |
540,334.33 |
所有者权益 |
实收基金 |
378,894,966.00 |
480,894,966.00 |
520,894,966.00 |
590,894,966.00 |
未分配利润 |
-129,172,213.05 |
-188,459,330.60 |
-221,405,762.76 |
-95,489,167.68 |
所有者权益合计 |
249,722,752.95 |
292,435,635.40 |
299,489,203.24 |
495,405,798.32 |
负债及所有者权益总计 |
250,610,591.14 |
292,833,452.44 |
300,312,099.27 |
495,946,132.65 |